V. G. Zhelobov

V. G. Zhelobov

Auto-generated profile, based on publicly available information

V. G. Zhelobov

Ye. A. Vagner Perm State Medical University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2023 in Perm Medical Journal
Verified
Journal Article
Open access
PDF file
PBP. N. Barlamov
P. N. Barlamov
EVE. R. Vasilyeva
E. R. Vasilyeva
VZV. G. Zholobov
V. G. Zholobov
To show the features of the clinical picture of this orphan disease and demonstrate the effectiveness of a long-term pathogenetic treatment of this disease using the case history of a patient with paroxysmal nocturnal hemoglobinuria (PNH) as an example. Complaints, anamnesis, physical status, as well as laboratory and instrumental studies used for a patient with PNH were presented. Modern literature data on the diagnosis and treatment of PNH have been studied. Complaints, anamnesis, physical status as well as laboratory and instrumental studies used for PNH patient were analyzed in comparison with the world literature data on this pathology. A conclusion was made regarding the need for a wide coverage of the clinical picture and diagnosis of PNH. The effectiveness of a long-term (for 13 years) pathogenetic treatment of the classical form of PNH with eculizumab was shown.

1 January 2022 in Russian Journal of Evidence-Based Gastroenterology
Verified
Journal Article
Closed access
PBP.N. Barlamov
P.N. Barlamov
OKO.V. Khlynova
O.V. Khlynova
EVE.R. Vasileva
E.R. Vasileva
VZV.G. Zhelobov
V.G. Zhelobov
ITI.P. Tokareva
I.P. Tokareva

26 September 2018 in Clinical Medicine (Russian Journal)
Verified
Journal Article
Open access
PBPavel Nikolaevich Barlamov
Pavel Nikolaevich Barlamov
EVE. R. Vasilieva
E. R. Vasilieva
MGM. E. Golubeva
M. E. Golubeva
VZV. G. Zelobov
V. G. Zelobov
OSO. S. Starikova
O. S. Starikova
ASA. A. Shutylev
A. A. Shutylev
The article presents a brief review of the literature on the current understanding of the etiology, pathogenesis, clinic, diagnosis and treatment of the acquired form of hemophilia, as well as the clinical case of this pathology with successful treatment.

15 October 2019 in The Clinician
Verified
Journal Article
Open access
PDF file
PBP. N. Barlamov
P. N. Barlamov
EVE. R. Vasilyeva
E. R. Vasilyeva
MGM. E. Golubeva
M. E. Golubeva
VZV. G. Zhelobov
V. G. Zhelobov
ASA. A. Shutylev
A. A. Shutylev
ТКТ. Ю. Кравцова
Т. Ю. Кравцова
The aim of the work is to describe the clinical case of formation, diagnosis and treatment of the acquired form of blood clotting factor VIII deficiency – of acquired hemophilia A.Material and methods. Patient R., 71 years, from April 2018, was found an acute hemorrhagic syndrome in the hematomic type of large hematomas manifested submandibular region, neck, chest, right breast, pubic and inguinal regions on the right, the anterior-medial surface of the left femur, anterior surface of left tibia. Standard laboratory tests, computed tomography of soft tissues of the neck, lungs, abdomen; coagulogram; blood clotting factors; inhibitor of factor VIII were evaluated in dynamics during the patient’s stay in the hospital; platelet aggregation function.Results. Typical gematomny type of bleeding, prolongation of coagulation indicators, the presence of the inhibitor factor VIII (7,0 BAA), the decrease in factor VIII (2 %) allowed diagnosis of acquired hemophilia A. Anti-inhibitory coagulant complex, fresh frozen plasma was successfully used for treatment. The patient is under observation in the regional Hematology center. The hematomas were not renewed.Conclusion. Our clinical observation demonstrates the features of the course, the algorithm of diagnosis and management of patients with of acquired hemophilia A.

4 January 2022 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
PBP. N. Barlamov
P. N. Barlamov
YTYu. I. Tretyakova
Yu. I. Tretyakova
VZV. G. Zhelobov
V. G. Zhelobov
OKO. V. Khlynova
O. V. Khlynova
ЮТЮ. И. Третьякова
Ю. И. Третьякова
Objective: To present a clinical description of the observation of a patient with Crohn’s disease (CD) with extraintestinal manifestations in the form of granulomatous alveolitis.Materials and Methods: A brief review of the literature on the current understanding of the prevalence and clinical manifestations of lung lesions in inflammatory bowel diseases (IBD) and CD, as well as a description of a patient with this pathology with the results of autopsy is presented.Results: The rare presence of granulomatous lung lesions in a patient with CD was proved.Conclusion: Difficulties in the differential diagnosis and treatment of CD lung lesions are shown. In particular, suspicion of tuberculous lesion, lung abscess creates potential risks of generalization of the process when using such therapeutic effects as glucocorticosteroids, cytostatics, immunosuppressants, biological genetically engineered drugs and active surgical intervention. The authors hope that the described observation will alert doctors in terms of possible systemic pulmonary lesions in CD.

11 September 2025 in Perm Medical Journal
Verified
Journal Article
Open access
PDF file
FTF. Ya. Tukhasheva
F. Ya. Tukhasheva
AMA. V. Markova
A. V. Markova
VZV. G. Zhelobov
V. G. Zhelobov
OGO. G. Goryacheva
O. G. Goryacheva
EME. G. Malelin
E. G. Malelin
ТЯТухашева Ф. Я.
Тухашева Ф. Я.
Over 37 million HIV-infected people live in the world and many of them die due to the progression and decompensation of somatic diseases. The aim of the study is to determine the rating of fatal outcomes causes of HIV-infected patients according to the data of the authors from different countries of the world. Data from 287 full-text articles were analyzed, from which 32 sources most relevant to the purpose of the study were selected. The leading causes of death in HIV-infected patients were infectious complications and opportunistic infections characteristic of the AIDS stage, along with concomitant tuberculosis infection (55.1 %). Cardiovascular diseases ranked second (20.6 %), followed by cancer (14.6 %), liver diseases, including alcoholic and viral hepatitis and cirrhosis (8.5 %), and only 1.1% are accounted for by all other diseases. Mortality from infective endocarditis, myocardial infarction, sudden cardiac death, acute cerebrovascular event, pulmonary embolism and acute decompensation of chronic heart failure together account for 82.5 % of all cardiovascular causes of mortality. Monitoring of patients with HIV infection should be comprehensive, involving infectious disease specialists, therapeutic and cardiology services, with increased cancer vigilance. The challenges of HIV infection concerning early development of cardiovascular pathology and elevated mortality from cardiovascular diseases should not be ignored.